- Home
- IZM vs SCLX Comparison
IZM vs SCLX Comparison
Compare IZM & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IZM
- SCLX
- Stock Information
- Founded
- IZM 2011
- SCLX 2011
- Country
- IZM China
- SCLX United States
- Employees
- IZM N/A
- SCLX N/A
- Industry
- IZM Consumer Electronics/Video Chains
- SCLX Biotechnology: Pharmaceutical Preparations
- Sector
- IZM Consumer Discretionary
- SCLX Health Care
- Exchange
- IZM Nasdaq
- SCLX Nasdaq
- Market Cap
- IZM 31.8M
- SCLX 35.7M
- IPO Year
- IZM 2023
- SCLX N/A
- Fundamental
- Price
- IZM $2.41
- SCLX $18.87
- Analyst Decision
- IZM
- SCLX Strong Buy
- Analyst Count
- IZM 0
- SCLX 3
- Target Price
- IZM N/A
- SCLX $367.50
- AVG Volume (30 Days)
- IZM 35.7K
- SCLX 324.6K
- Earning Date
- IZM 09-02-2025
- SCLX 08-13-2025
- Dividend Yield
- IZM N/A
- SCLX N/A
- EPS Growth
- IZM N/A
- SCLX N/A
- EPS
- IZM N/A
- SCLX N/A
- Revenue
- IZM $180,553,977.00
- SCLX $44,236,000.00
- Revenue This Year
- IZM N/A
- SCLX $89.26
- Revenue Next Year
- IZM N/A
- SCLX $203.95
- P/E Ratio
- IZM N/A
- SCLX N/A
- Revenue Growth
- IZM N/A
- SCLX N/A
- 52 Week Low
- IZM $1.18
- SCLX $3.60
- 52 Week High
- IZM $3.19
- SCLX $45.15
- Technical
- Relative Strength Index (RSI)
- IZM 40.86
- SCLX 63.34
- Support Level
- IZM $2.34
- SCLX $15.61
- Resistance Level
- IZM $2.61
- SCLX $22.01
- Average True Range (ATR)
- IZM 0.08
- SCLX 2.21
- MACD
- IZM -0.02
- SCLX -0.14
- Stochastic Oscillator
- IZM 24.14
- SCLX 62.35
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.